Alembic (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Alembic Limited |
|||
|
Price: ₹139.47 | ||
| 52 Week Low: ₹78.10 52 Week High: ₹169.00 |
|||
| Market Capital: 3,165.09 Crore (Smallcap) | |||
| Real Estate -> Real Estate - Development | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Alembic Share Price Target For 2024
- 1.1.1: Alembic Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Alembic Share Price Target For 2025
- 1.2.1: Alembic Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Alembic Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Alembic Brief Company Overview
- 4: Alembic Financial Performance
- 4.0.1: Is Alembic A Good Buy For Long Term?
To predict the Alembic's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Alembic Share Price Target For 2024
The line chart displays the monthly closing prices of Alembic with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Alembic shares in 2024, see the table below.
Alembic Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 146.81 (+5.26%) | Price Action: 18 Dec 2024 High |
| 2024 Target 2 | 145.08 (+4.02%) | Fibonacci Extension Level 23.60% |
| 2024 Target 1 | 143.61 (+2.96%) | Price Action: 13 Dec 2024 Low |
| Current Price | 139.47 | Alembic's share price as of 20 Dec 2024 |
| Stop Loss 1 | 137.98 (-1.07%) | Price Action: 04 Dec 2024 High |
| Stop Loss 2 | 136.31 (-2.27%) | Price Action: 06 Dec 2024 Low |
| Stop Loss 3 | 134.81 (-3.35%) | Price Action: 08 Nov 2024 High |
Short-Term Technical Outlook
Current Technical Position: Alembic is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 25-day moving average at ₹135.96 serves as the nearest technical reference point.
Historical Returns: 3-month: -1.33% | 6-month: +26.99% | 1-year: +56.67%
Alembic Share Price Target For 2025
The line chart displays the monthly closing prices of Alembic with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Alembic shares in 2025, see the table below.
Alembic Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 203.75 (+46.08%) | Price Action: Chart |
| 2025 Target 2 | 199.95 (+43.36%) | Price Action: Chart |
| 2025 Target 1 | 197.97 (+41.94%) | Fibonacci Extension Level 64.90% |
| Current Price | 139.47 | Alembic's share price as of 20 Dec 2024 |
| Stop Loss 1 | 125.9 (-9.73%) | Price Action: 22 Nov 2024 High |
| Stop Loss 2 | 124.64 (-10.64%) | Price Action: 28 Oct 2024 High |
| Stop Loss 3 | 123.08 (-11.76%) | Price Action: 18 Nov 2024 Low |
Long-Term Technical Outlook
52-Week Range Analysis: Alembic is currently trading at 67.5% of its 52-week range (₹78.1 - ₹169).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +56.67% | 3-year: +40.18% | 5-year: +152.85%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Alembic Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹139.47 | ||
| 2024 | ₹148.46 | +6.45% | ₹150.69 |
| 2025 | ₹178.93 | +20.52% | ₹181.61 |
| 2026 | ₹203.57 | +13.77% | ₹206.62 |
| 2027 | ₹235.49 | +15.68% | ₹239.02 |
| 2028 | ₹258.13 | +9.61% | ₹275.20 |
| 2029 | ₹317.44 | +22.98% | ₹322.20 |
| 2030 | ₹344.82 | +8.63% | ₹349.99 |
| 2031 | ₹362.79 | +5.21% | ₹368.23 |
| 2032 | ₹394.76 | +8.81% | ₹401.93 |
| 2033 | ₹411.92 | +4.35% | ₹444.17 |
| 2034 | ₹486.42 | +18.09% | ₹493.72 |
| 2035 | ₹510.72 | +5.00% | ₹518.38 |
| 2036 | ₹522.01 | +2.21% | ₹529.84 |
| 2037 | ₹554.02 | +6.13% | ₹570.91 |
| 2038 | ₹565.70 | +2.11% | ₹613.15 |
| 2039 | ₹652.69 | +15.38% | ₹662.48 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Alembic Brief Company Overview
Alembic Limited: A Well-Established Pharmaceutical Manufacturer Founded in 1907, Alembic Limited is a leading Indian pharmaceutical company with a strong presence in the manufacturing and marketing of fermentation and chemistry-based active pharmaceutical ingredients (APIs)....
Operating through its API and Real Estate segments, the company has a diverse product range catering to various therapeutic areas. Beyond APIs, Alembic Limited is actively involved in real estate development and leasing, offering residential and commercial projects along with project management and marketing consultancy services. The company's commitment to sustainability is evident in its operation of co-generation and wind power plants, contributing to a greener future. Alembic Limited's reputation in the industry is built upon its unwavering focus on quality, innovation, and customer satisfaction. Its dedication to delivering effective and affordable healthcare solutions has earned the company a loyal customer base and a strong reputation among healthcare professionals.Alembic Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 3,165.09 Crore | Market valuation of Alembic's shares. |
| Revenue (TTM) | 171.42 Crore | Total revenue generated by Alembic over the past twelve months. |
| Net Income (TTM) | +2,800,591,104.00 | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +35.25% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +163.37% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+37.79% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+25.80% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
0.41 | Company's total debt divided by total shareholder equity. |
| Total Debt | 9.14 Crore | Sum of Alembic's current & long-term financial obligations. |
| Total Cash | 12.85 Crore | Total amount of liquid funds available to Alembic. |
| Beta | 1.1 | Beta is greater than 1 indicating that the Alembic's price is more volatile than the market. |
Is Alembic A Good Buy For Long Term?
Alembic, a small-cap stock with a market capitalization of ₹3,165.09 crore, shows mixed signals. While its impressive 5-year return of 211.59% and strong YTD return of 37.13% are positive, a net profit of ₹280.05 crore exceeding revenue (163.37% profit margin) warrants further investigation. The recent -17.04% return over the past three months raises concerns. With low debt (₹9.14 crore) and positive cash balance (₹12.85 crore), it's a moderate buy for the long term, requiring careful monitoring of its profitability and revenue growth consistency.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
